Literature DB >> 4037494

Comparative pharmacokinetics and anesthetic effects of methohexital, pentobarbital, thiamylal, and thiopental in Greyhound dogs and non-Greyhound, mixed-breed dogs.

R A Sams, W W Muir, R L Detra, E P Robinson.   

Abstract

Pharmacokinetics and duration of anesthesia of methohexital, pentobarbital, thiamylal, and thiopental in Greyhound and non-Greyhound, mixed-breed dogs were compared. In all dogs evaluated, pentobarbital induced the longest duration of anesthesia and methohexital induced the shortest duration. Pharmacokinetics of pentobarbital and methohexital were similar in both groups of dogs. Thiobarbiturates induced longer anesthetic effects in Greyhound dogs than in mixed-breed dogs. Plasma thiobarbiturate concentrations remained above normal longer in Greyhound dogs than in mixed-breed dogs. Disposition of thiobarbiturates in Greyhound dogs was characterized by nonlinearity from 45 minutes to 8 hours after dosing.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4037494

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  5 in total

Review 1.  Factors influencing the bioavailability of peroral formulations of drugs for dogs.

Authors:  S Sabnis
Journal:  Vet Res Commun       Date:  1999-11       Impact factor: 2.459

2.  Pharmacokinetics of the cytochrome P-450 substrates phenytoin, theophylline, and diazepam in healthy Greyhound dogs.

Authors:  B KuKanich; J L Nauss
Journal:  J Vet Pharmacol Ther       Date:  2011-06-22       Impact factor: 1.786

Review 3.  Clinical pharmacokinetics in veterinary medicine.

Authors:  J D Baggot
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

4.  Chronic ocular hypertension alters local retinal responsiveness.

Authors:  R Ofri; W W Dawson; K Foli; K N Gelatt
Journal:  Br J Ophthalmol       Date:  1993-08       Impact factor: 4.638

5.  Canine cytochrome P-450 pharmacogenetics.

Authors:  Michael H Court
Journal:  Vet Clin North Am Small Anim Pract       Date:  2013-06-13       Impact factor: 2.093

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.